Tish Eggleston Pahl is a principal at OFW Law. She is regulatory counsel to drug, cosmetic, dietary supplement, and food clients with concerns before the Food and Drug Administration, the Federal Trade Commission, and other federal agencies. Her work has encompassed representation of companies making and marketing human and animal prescription and over-the-counter (OTC) drugs, dietary supplements, and cosmetics. She has particular expertise in the areas of medical product supply chain integrity, health care communications, health care policy and legislation, regulatory compliance, open payments requirements, advertising, and labeling of FDA-regulated products, and advocacy of commercial First Amendment speech rights under the United States Constitution. Further, she advises trade association clients on a range of antitrust and trade regulation issues. Tish closely monitors and analyzes the rapidly changing legislative, regulatory, and legal environment for a variety of health care clients.
Since November 2013, Tish has been heavily involved with implementation of the Drug Quality and Security Act or DQSA. She has advised pharmacy compounders and outsourcing facilities on their new FDA responsibilities under Title I of the DQSA. She has worked closely with pharmaceutical supply chain stakeholders, including manufacturers, repackagers, wholesale distributors, and dispensers on implementation of Title II of the DQSA, the Drug Supply Chain Security Act or DSCSA.
Tish also specializes in crafting cost-effective risk and compliance strategies for small businesses and entrepreneurs seeking to introduce OTC and homeopathic drugs, cosmetics, and dietary supplements into the market. She also has advised clients on the developing areas of product stewardship and disposal of pharmaceuticals.